Microbial Identification

Newark, United States Founded: 1991 • Age: 35 yrs Acquired By Biolog
Chemical data analysis and microbial identification solutions are offered.

About Microbial Identification

Microbial Identification is a Healthcare company based in Newark (United States) founded in 1991, and was acquired by Biolog in January 2023. Chemical data analysis and microbial identification solutions are offered. Its focus areas include Life Sciences, Genomics, Genome Informatics and Sequence Analysis. Its competitors include Insitro, DNAnexus and HotSpot Therapeutics; 3 of its 3 listed competitors have raised funding.

Company details

Microbial Identification Inc (MIDI) offers chemical data analysis and pattern recognition solutions. Products include Sherlock Microbial Identification System (MIS) - solution for the identification of over 1,500 microbial species, fatty acids and PLFAs by GC-FAME analysis; Sherlock PLFA Method and Tools Package (PLFAD1) which names over 150 PLFAs and related compounds and can be used for fatty acid analysis; Sherlock Mycobacteria Identification System (MYCO-LCS) - solution for the identification of Mycobacterium tuberculosis and 60 other mycobacteria and related species that produce mycolic acids; DNA sequencing software; and X Fire Debris Analysis Software solution. microbial Identification Inc (MIDI) group provides solutions for food, forensics,agriculture, pharmaceutical, biotech, and public health. Products include Sherlock Microbial Identification System for the identification of over 1,500 microbial species, fatty acids and PLFAs by GC-FAME analysis, Phospholipid Fatty Acid Analysis (PLFA) system, Mycobacteria Identification System (MYCO-LCS) for the identification of Mycobacterium tuberculosis Sherlock DNA Sequencing software and fire debris analysis solution which combines Sherlock X software and methods with an Agilent GC-MS and Agilent ChemStation analysis software.

Key Metrics
  • Latest Funding Round
    $148.64K (USD), Grant

    Sep 2018

  • Investors
    HHS

    & 1 more

  • Acquired by
    Biolog

    (Jan 2023)

Funding Insights of Microbial Identification

  • Total Rounds 3
  • Last Round Grant β€” $148,641
  • First Round $99,156

    (Apr 2008)

  • Investors Count 1

All 3 funding rounds of Microbial Identification with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Sep 2018$148,641Grant––
Apr 2008$99,156Grant––
Apr 2008$99,156Grant––
Valuation history

2 investors in total: 2 institutional.

Investors in Microbial Identification

Microbial Identification has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include HHS and Biolog.

All
Institutional
InvestorDescriptionFounded YearDomainLocation
Public health and human services are overseen by HHS.
1953hhs.gov
Cell-based phenotyping technologies and assays are provided for microbial analysis.
1984biolog.comHayward, United States
Premium access

Investor details for Microbial Identification

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

Timeline of Microbial Identification

4 dated milestones of Microbial Identification across 32 years, from founding to its latest funding, stage changes and deals.

  1. Founded Microbial Identification is founded.
  2. Funding First funding round of $99K.
  3. Funding Latest funding round, Grant, of $149K.
  4. Exit Acquired by Biolog.

Competitors of Microbial Identification

Microbial Identification has 3 listed competitors in our database, 3 of them funded. They include Insitro, DNAnexus and HotSpot Therapeutics.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
insitro.com2018San Francisco, United States$643.21M257
An AI-enabled platform is developed for infectious disease treatment.
dnanexus.com2009Mountain View, United States$472.55M143
Cloud-based genome informatics and data management are provided.
hotspotthera.com2017Boston, United States$210M37
Developer of a platform for protein function analysis
Premium access

Detailed competitors of Microbial Identification

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Web traffic of Microbial Identification

Websites that share an audience with Microbial Identification (midi-inc.com).

Similar websites

Websites whose visitors overlap most with Microbial Identification. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
ipmscientific.com
ipmscientific.com
100%
#15,074,270–
philombios.com
philombios.com
100%
–
alken-murray.com
100%
#8,460,723View details
qlaboratories.com
100%
5.1K#3,709,140View details
titanbiotechltd.com
100%
14.6K#1,498,243View details
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
Premium access

All 22 similar websites and full traffic analytics for Microbial Identification

The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.

  • 22 similar websites
  • Audience overlap
  • Engagement analytics
  • Traffic by brand

Verified entity values are shown only after access is granted.

Top companies in Genomics & Gene Therapy Platforms

3 companies that operate in the same segment as Microbial Identification (Genomics & Gene Therapy Platforms) in United States, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
mRNA-based therapeutics for diseases including cancer and infections are developed.
2010Cambridge, Massachusetts, United StatesUSD 2.78 BUSD 1.94 B5,800
Digital sequencing technology for cancer detection is developed.
2012Redwood City, California, United StatesUSD 557.5 MUSD 982.02 M4,867
Circulating tumor DNA is screened for early cancer detection.
2016Menlo Park, California, United StatesUSD 2 BUSD 147.17 M1,141
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Microbial Identification

Premium access

Complete news archive for Microbial Identification

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Microbial Identification

Microbial Identification was founded in 1991 and raised its 1st funding round 17 years after it was founded.

Microbial Identification is headquartered in Newark, United States. It is registered at Newark, New Jersey, United States.

Microbial Identification Inc (MIDI) offers chemical data analysis and pattern recognition solutions. Products include Sherlock Microbial Identification System (MIS) - solution for the identification of over 1,500 microbial species, fatty acids and PLFAs by GC-FAME analysis; Sherlock PLFA Method and Tools Package (PLFAD1) which names over 150 PLFAs and related compounds and can be used for fatty acid analysis; Sherlock Mycobacteria Identification System (MYCO-LCS) - solution for the identification of Mycobacterium tuberculosis and 60 other mycobacteria and related species that produce mycolic acids; DNA sequencing software; and X Fire Debris Analysis Software solution. microbial Identification Inc (MIDI) group provides solutions for food, forensics,agriculture, pharmaceutical, biotech, and public health. Products include Sherlock Microbial Identification System for the identification of over 1,500 microbial species, fatty acids and PLFAs by GC-FAME analysis, Phospholipid Fatty Acid Analysis (PLFA) system, Mycobacteria Identification System (MYCO-LCS) for the identification of Mycobacterium tuberculosis Sherlock DNA Sequencing software and fire debris analysis solution which combines Sherlock X software and methods with an Agilent GC-MS and Agilent ChemStation analysis software.

Microbial Identification's top competitors include Insitro, DNAnexus and HotSpot Therapeutics.

Microbial Identification has 2 investors. Key investors include HHS, and Biolog.

Yes. Microbial Identification was acquired by Biolog in January 2023.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available